Tsujita; Yoshio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tsujita; Yoshio.The latest application filed is for "pharmaceutical compositions and methods for the treatment or prophylaxis of arteriosclerosis".

Company Profile

0.12.1

Tsujita; Yoshio - Ichikawa JP
Tsujita, Yoshio - Ichikawa-shi JP
Tsujita; Yoshio - Tokyo JP
Tsujita; Yoshio - Hiromachi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical compositions and methods for the treatment of arteriosclerosis Grant 6,610,682 - Tsujita , et al. August 26, 2	2003-08-26
Pharmaceutical compositions and methods for the treatment or prophylaxis of arteriosclerosis App 20020013308 - Tsujita, Yoshio ; et al.	2002-01-31
Treatment of arteriosclerosis and xanthoma Grant 6,159,997 - Tsujita , et al. December 12, 2	2000-12-12
Treatment of arteriosclerosis and xanthoma Grant 5,798,375 - Tsujita , et al. August 25, 1	1998-08-25
Radicicol derivatives, their preparation and their anti-tumor activity Grant 5,650,430 - Sugimura , et al. July 22, 1	1997-07-22
Radicicol derivatives, their preparation and their anti-tumor activity Grant 5,597,846 - Sugimura , et al. January 28, 1	1997-01-28
Enzyme-inhibitory griseolic acid derivatives, and their use Grant 4,822,879 - Nakagawa , et al. April 18, 1	1989-04-18
Octahydronaphthalene derivatives and their preparation Grant 4,733,003 - Ide , et al. March 22, 1	1988-03-22
Octahydronaphthalene derivatives and their preparation Grant 4,604,472 - Ide , et al. August 5, 1	1986-08-05
Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use Grant 4,361,515 - Terahara , et al. November 30, 1	1982-11-30
Preparation of Monacolin K Grant 4,323,648 - Tanzawa , et al. April 6, 1	1982-04-06
Physiologically active substances and fermentative process for producing the same Grant 4,049,495 - Endo , et al. September 20, 1	1977-09-20
Physiologically active substances Grant 3,983,140 - Endo , et al. September 28, 1	1976-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.